1. Home
  2. BLLN vs MAT Comparison

BLLN vs MAT Comparison

Compare BLLN & MAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$118.17

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Logo Mattel Inc.

MAT

Mattel Inc.

HOLD

Current Price

$13.98

Market Cap

4.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
MAT
Founded
2016
1945
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.5B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
BLLN
MAT
Price
$118.17
$13.98
Analyst Decision
Buy
Buy
Analyst Count
7
11
Target Price
$126.71
$20.90
AVG Volume (30 Days)
782.3K
3.9M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
N/A
$5,347,623,000.00
Revenue This Year
$46.29
$5.92
Revenue Next Year
$30.14
$5.08
P/E Ratio
N/A
$69.10
Revenue Growth
N/A
N/A
52 Week Low
$61.96
$13.62
52 Week High
$138.70
$22.48

Technical Indicators

Market Signals
Indicator
BLLN
MAT
Relative Strength Index (RSI) 67.16 39.65
Support Level $79.07 N/A
Resistance Level $138.70 $15.38
Average True Range (ATR) 6.87 0.46
MACD 1.10 -0.03
Stochastic Oscillator 97.91 20.62

Price Performance

Historical Comparison
BLLN
MAT

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About MAT Mattel Inc.

Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the remainder stemming from international markets.

Share on Social Networks: